NCT00101478

Brief Summary

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study will aim to improve provider and patient approaches to treatment of hypertension and diabetes, respectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
823

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2004

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 11, 2005

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

May 11, 2021

Status Verified

May 1, 2021

Enrollment Period

6.3 years

First QC Date

January 10, 2005

Last Update Submit

May 6, 2021

Conditions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study groups will be selected from primary and family health clinics, community, and patients of physicians participating in the study.

You may qualify if:

  • Uncontrolled hypertension or diabetes

You may not qualify if:

  • Medical condition that would prevent treatment for hypertension at the University of Maryland
  • Medical condition that would prevent treatment for diabetes at Bon Secours
  • Uninsured

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Maryland Baltimore

Baltimore, Maryland, 21201, United States

Location

Bon Secours Hospital

Baltimore, Maryland, 21223, United States

Location

MeSH Terms

Conditions

Cardiovascular DiseasesHeart DiseasesDiabetes MellitusHypertension

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular Diseases

Study Officials

  • Elijah Saunders, MD

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR
  • Reed Winston, MD

    Bon Secours Hospital Baltimore

    PRINCIPAL INVESTIGATOR
  • Fadia T. Shaya, PhD, MPH

    Universitiy of Maryland Baltimore

    PRINCIPAL INVESTIGATOR
  • Wallace R. Johnson, MD

    Bon Secours Hospital Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2005

First Posted

January 11, 2005

Study Start

September 1, 2004

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

May 11, 2021

Record last verified: 2021-05

Locations